Literature DB >> 15291012

Experience with zolpidem 'as needed' in primary care settings.

Göran Hajak1, Peter Geisler.   

Abstract

'As needed' non-nightly intake of hypnotic agents by patients suffering from chronic insomnia is likely to offer benefits such as maintained efficacy while preventing unnecessary long-term nightly use associated with the risk of tolerance and dependence. To date, three studies have proven the 'as needed' approach with zolpidem in patients with primary insomnia treated in outpatient practice. In total, more than 3000 primary care patients, proved that flexible or semi-flexible schedules of zolpidem 'as needed' treatment are feasible. In all the studies, 'as needed' zolpidem treatment was both effective and well tolerated by the patients. Moreover, the results of these studies clearly indicated that chronic insomniac patients are capable of limiting their hypnotic intake, showing no tendency to increase intake over time and even a trend to decreasing use of medication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291012     DOI: 10.2165/00023210-200418001-00007

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  6 in total

1.  Insomnia in primary care.

Authors:  G Hajak
Journal:  Sleep       Date:  2000-05-01       Impact factor: 5.849

2.  Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study.

Authors:  G Hajak; R Cluydts; A Declerck; S Eduard Estivill; A Middleton; K Sonka; M Unden
Journal:  Int Clin Psychopharmacol       Date:  2002-01       Impact factor: 1.659

Review 3.  [Psychological, psychotherapeutic and other non-pharmacologic forms of therapy in treatment of insomnia. Position of the "Insomnia" Study Group of the German Society of Sleep Research and Sleep Medicine].

Authors:  G Hajak; K Müller-Popkes; D Riemann; G Mayer; C Lauer
Journal:  Fortschr Neurol Psychiatr       Date:  1997-03       Impact factor: 0.752

4.  Eight weeks of non-nightly use of zolpidem for primary insomnia.

Authors:  J K Walsh; T Roth; A Randazzo; M Erman; A Jamieson; M Scharf; P K Schweitzer; J C Ware
Journal:  Sleep       Date:  2000-12-15       Impact factor: 5.849

5.  Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study.

Authors:  R Cluydts; K Peeters; I de Bouyalsky; J Lavoisy
Journal:  J Int Med Res       Date:  1998 Jan-Feb       Impact factor: 1.671

6.  "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting.

Authors:  Göran Hajak; Borwin Bandelow; Jürgen Zulley; David Pittrow
Journal:  Ann Clin Psychiatry       Date:  2002-03       Impact factor: 1.567

  6 in total
  1 in total

1.  An approach to long-term sedative-hypnotic use.

Authors:  Azmeh Shahid; Sharon A Chung; Ron Phillipson; Colin M Shapiro
Journal:  Nat Sci Sleep       Date:  2012-04-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.